Evaluate the Safety and Tolerability of INCB019602 When Administered With Metformin in Patients With Type 2 Diabetes
Status:
Terminated
Trial end date:
2009-06-01
Target enrollment:
Participant gender:
Summary
Determine the effect of treatment with INCB019602 administered as an add-on to stable dose
metformin therapy in type 2 diabetic subjects on safety and glycemic control.